Garetosmab, CAS 2097125-54-5

Product Description: Garetosmab (REGN 2477) is a fully human IgG4 monoclonal antibody that specifically inhibits activin A. Garetosmab can be used for fibrodysplasia ossificans progressiva (FOP) research[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Frédéric Vanhoutte, et al. Pharmacokinetics and Pharmacodynamics of Garetosmab (Anti-Activin A): Results From a First-in-Human Phase 1 Study. J Clin Pharmacol. 2020 Nov;60(11):1424-1431.

CAS Number: 2097125-54-5

Molecular Weight: N/A

Compound Purity: 95.0

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: TGF-β Receptor

• SKU: MEXHY-P99632-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99632-10
• Package Unit: 10 mg
• Quantity Unit: STK
• Conjugate: Unconjugated